Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/19692
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVan de Velde, H.en
dc.contributor.authorGeorgiou, I.en
dc.contributor.authorDe Rycke, M.en
dc.contributor.authorSchots, R.en
dc.contributor.authorSermon, K.en
dc.contributor.authorLissens, W.en
dc.contributor.authorDevroey, P.en
dc.contributor.authorVan Steirteghem, A.en
dc.contributor.authorLiebaers, I.en
dc.date.accessioned2015-11-24T19:01:28Z-
dc.date.available2015-11-24T19:01:28Z-
dc.identifier.issn0268-1161-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/19692-
dc.rightsDefault Licence-
dc.subjectEmbryo Transferen
dc.subjectFemaleen
dc.subjectFertilization in Vitroen
dc.subjectHLA Antigens/*analysis/classification/geneticsen
dc.subjectHumansen
dc.subjectMicrosatellite Repeatsen
dc.subjectOvulation Inductionen
dc.subjectPolymerase Chain Reactionen
dc.subjectPregnancyen
dc.subjectPregnancy Rateen
dc.subjectPreimplantation Diagnosis/*methodsen
dc.subjectbeta-Thalassemia/*diagnosisen
dc.titleNovel universal approach for preimplantation genetic diagnosis of beta-thalassaemia in combination with HLA matching of embryosen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1093/humrep/deh153-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/14998973-
heal.identifier.secondaryhttp://humrep.oxfordjournals.org/content/19/3/700.full.pdf-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2004-
heal.abstractBACKGROUND: Beta-Thalassaemia results from co-inheritance of two mutant beta-globin alleles. Allogeneic cord blood cell transplantation (CBT) from an HLA-identical sibling donor is an excellent treatment option for beta-thalassaemia. In families with an affected child and willing to have another child, IVF followed by preimplantation genetic diagnosis (PGD) can be applied to exclude affected embryos. Furthermore, healthy embryos could be HLA matched with the affected child so that cord blood from the future newborn can be used to transplant the affected sibling. METHODS: We developed an indirect single-cell HLA typing technique based on the use of a bank of seven microsatellite markers within the HLA locus from which four informative and evenly distributed markers were selected. RESULTS: The methodology was validated in three beta-thalassaemia families having six ovarian stimulation cycles in view of IVF and PGD. Six PGD cycles were performed in two families. On 58 embryos tested, the combined PCR was successful in 54 (93%). Two transfers were done and one clinical pregnancy was obtained. Using confirmatory analysis on 50 embryos, the accuracy for HLA typing was 100%. CONCLUSION: This strategy offers a new therapeutic option for patients with beta-thalassaemia and other monogenic diseases that can be cured with CBT.en
heal.journalNameHum Reproden
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Van de Velde-2004-Novel universal appr.pdf150 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons